|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$2,383,555
|
$238,355
|
Alter, Blanche
|
DCEG (NCI)
|
|
Molecular Studies of Cellular Cytotoxicity
|
ZIA BC 010013
|
$791,415
|
$158,283
|
Anderson, Stephen
|
CCR (NCI)
|
|
Collaborative Pathways that Lead to Leukemia
|
ZIA BC 010982
|
$443,718
|
$44,372
|
Aplan, Peter
|
CCR (NCI)
|
|
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
|
ZIA BC 010983
|
$380,330
|
$380,330
|
Aplan, Peter
|
CCR (NCI)
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
3P30CA142543-08S1
|
$175,000
|
$5,250
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-08
|
$2,480,000
|
$74,400
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
T cell receptor proximal signaling
|
ZIA BC 011715
|
$279,574
|
$139,787
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S2
|
$60,000
|
$1,200
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S3
|
$100,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Pediatric Oncology Research Training Program
|
2T32CA009351-39
|
$272,307
|
$108,923
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-17
|
$701,719
|
$231,567
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
T cell Development and Regeneration
|
ZIA BC 011633
|
$1,082,718
|
$1,082,718
|
Bhandoola, Avinash
|
CCR (NCI)
|
|
Cytotoxic-T-Lymphocyte (CTL) Therapy of AML
|
5R01CA072669-20
|
$294,076
|
$294,076
|
BLAZAR, BRUCE
|
UNIVERSITY OF MINNESOTA
|
|
Effects of PGE2 on reconstitution of hematopoiesis and immunity after UCBT
|
5R01CA183605-05
|
$894,037
|
$894,037
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
5P30CA196521-03
|
$2,373,000
|
$118,650
|
BURAKOFF, STEVEN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Metabolic basis of chronic graft-versus-host disease
|
ZIA BC 011725
|
$24,641
|
$24,641
|
Buxbaum, Nataliya
|
CCR (NCI)
|
|
In vivo cell kinetics and imaging of chronic graft-versus-host-disease
|
ZIA BC 011727
|
$24,641
|
$24,641
|
Buxbaum, Nataliya
|
CCR (NCI)
|
|
Chronic graft-versus-host disease in children and young adults
|
ZID BC 011729
|
$8,214
|
$5,750
|
Buxbaum, Nataliya
|
CCR (NCI)
|
|
Targeting Granzyme B to Separate GVH from GVL Responses
|
5R01CA184728-03
|
$401,456
|
$401,456
|
CAO, XUEFANG
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Targeting Beta-Adrenergic Signaling to Control GVH and GVL Responses
|
5R21CA202358-02
|
$189,334
|
$189,334
|
CAO, XUEFANG
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Inhibiting STAT1 as a novel graft-versus-host/graft-versus-leukemia therapy
|
5K08CA174750-04
|
$178,740
|
$178,740
|
CAPITINI, CHRISTIAN
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
|
ZIA BC 010791
|
$842,389
|
$84,239
|
Carrington, Mary
|
CCR (NCI)
|
|
Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W
|
5K08CA169485-05
|
$171,372
|
$171,372
|
CHAPUIS, AUDE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Intervention of Immune Tolerance by Small Molecules
|
5R01CA127483-09
|
$341,161
|
$341,161
|
CHEN, SHU-HSIA
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The role and functional mechanism of TET1 in MLL-rearranged leukemia
|
5R01CA178454-05
|
$327,850
|
$163,925
|
CHEN, JIANJUN
|
UNIVERSITY OF CINCINNATI
|
|
Histology Core Laboratory
|
ZIC BC 010687
|
$1,344,149
|
$403,245
|
Chinquee, Joseph
|
CCR (NCI)
|
|
Chronic graft-versus-host disease
|
ZIA BC 011549
|
$101,251
|
$50,625
|
Cowen, Edward
|
CCR (NCI)
|
|
Dermatology Consultation Service
|
ZID BC 011317
|
$253,127
|
$63,282
|
Cowen, Edward
|
CCR (NCI)
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-09
|
$2,524,399
|
$1,262,200
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S1
|
$59,999
|
$30,000
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S2
|
$102,081
|
$51,041
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease
|
5P01CA142106-13
|
$1,630,446
|
$1,532,619
|
CUTLER, COREY
|
DANA-FARBER CANCER INST
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
5T32CA009515-33
|
$570,788
|
$142,697
|
DAVIDSON, NANCY
|
UNIVERSITY OF WASHINGTON
|
|
A phase IIA trial for the safety and tolerability of CD24Fc in prophylaxis of graft vs host disease.
|
1R44CA221513-01
|
$1,017,478
|
$1,017,478
|
DEVENPORT, MARTIN
|
ONCOIMMUNE, INC.
|
|
Cancer Center Support Grant P30
|
3P30CA093373-15S1
|
$125,000
|
$5,000
|
DEVERE WHITE, RALPH
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Cancer Center Support Grant P30
|
3P30CA093373-15S2
|
$89,478
|
$3,579
|
DEVERE WHITE, RALPH
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
CMVPepVax to Protect HCT Recipients from Cytomegalovirus Infection
|
5R01CA181045-04
|
$710,976
|
$710,976
|
DIAMOND, DON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Role of ErbB receptor signaling in regulating normal and leukemic stem cell fate
|
5K08CA184552-04
|
$127,865
|
$38,360
|
DOAN, PHUONG
|
DUKE UNIVERSITY
|
|
Investigating the role of interleukin-22 in thymus function
|
5R00CA176376-03
|
$247,118
|
$123,559
|
DUDAKOV, JARROD
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Optimal Antiretroviral Therapy During Bone Marrow Transplant in HIV-1 Infection
|
5K23CA177321-04
|
$161,608
|
$161,608
|
DURAND, CHRISTINE
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-16S1
|
$122,824
|
$1,228
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-16S2
|
$243,947
|
$2,439
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA091842-16
|
$4,305,712
|
$43,057
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
SPORE in Myeloid Malignancies
|
1P50CA206963-01A1
|
$2,185,000
|
$131,100
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells
|
5R01CA182947-04
|
$321,933
|
$321,933
|
FARAG, SHERIF
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S3
|
$6,166,044
|
$184,981
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S4
|
$50,000
|
$1,500
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S5
|
$30,973
|
$929
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
Cellular and Molecular Studies of Bone Marrow Transplant
|
5P01CA039542-29
|
$2,037,038
|
$753,704
|
FERRARA, JAMES
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
City of Hope Lymphoma SPORE
|
3P50CA107399-10S1
|
$300,000
|
$75,000
|
FORMAN, STEPHEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
Total relevant funding to Bone Marrow Transplantation for this search: $39,362,912
|